References
- [1] Bäck M. Leukotriene signaling in atherosclerosis and
ischemia. Cardiovasc Drugs Ther. 2009;23:41–48.
- [2] Bennett AM, Williams GM. Reduction of rat liver endoplasmic reticulum Ca2+-ATPase activity and mobilization of hepatic intracellular calcium by ciprofibrate, a peroxisome proliferator. Biochem. Pharmacol. 1992;43:595–605.
- [3] Cinti DL, Moldeus P, Schenkman JB. Kinetic parameters of
drug-metabolizing enzymes in Ca2+-sedimented microsomes
from rat liver. Biochem Pharmacol. 1972;21:3249–56.
- [4] Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal.Biochem. 1976;72:248–254.
- [5] Feltenmark S, Gautam N, Brunnström A, Griffiths W, Backman
L, Edenius Ch, Lindbom L, Björkholm M, Claesson
HE. Eoxins are proinflammatory arachidonic acid metabolites
produced via the 15-lipoxygenase-1 pathway in
human eosinophils and mast cells. Proc. Natl. Acad. Sci.
USA 2008;105:680–685.
- [6] Grundy SM. Obesity, Metabolic Syndrome, and Cardiovascular
Disease. The Journal of Clinical Endocrinology &
Metabolism 2004;89:2595–2600.
- [7] Hogaboom GK, Cook M, Newton JF, Varrichio A, Shorr RG, Sarau HM, Crooke ST. Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities. Mol. Pharmacol. 1986;30:509–510.
- [8] Chakrabarti SK, Cole BK, Wen Y, Keller SR, Nadler JL.
12/15-Lipoxygenase Products Induce Inflammation and
Impair Insulin Signaling in 3T3-L1 Adipocytes. Obesity
2009;17:1657–1663.
- [9] Jiao HL, Zhao BL. Cytotoxic Effect of Peroxisome Proliferator
Fenofibrate on Human HepG2 Hepatoma Cell Line
and Relevant Mechanisms. Toxicology and Applied Pharmacology
2002;185:172–179.
- [10] Kemal, C, Louis-Flamberg P, Krupinsky-Olsen R, Shorter
AL. Reductive inactivation of soybean lipoxygenase
1 by catechols: a possible mechanism for regulation
of lipoxygenase activity. Biochemistry 1987;26:7064–
7072.
- [11] Laemmli UK. Cleavage of structural proteins during
the assembly of the head of bacteriophage T4. Nature
1970;227:680–685.
- [12] Nesterenko MV, Tilley M, Upton SJ. A simple modification of Blum’s silver stain method allows for 30 minute detection of proteins in polyacrylamide gels. J. Biochem. Biophys. Methods 1994;28:239–242.
- [13] Pace-Asciak CR. The hepoxilins and some analogues: a review of their biology. Brit. J. Pharm. 2009;158:972–981.
- [14] Radmark O, Werz O, Steinhilber D. 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem. Sci. 2007;32:332–341.
- [15] Riccioni G, Zanasi A, Vitulano N, Mancini B, D’orazio N.
Leukotrienes in Atherosclerosis: New Target Insights
and Future Therapy Perspectives. Mediators of Inflamm.
2009;Article ID 737282, 6 pages.
- [16] Romano M. Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins. Inflamm. Allergy Drug Targets 2006;5: 81–90.
- [17] Schindler CH. The metabolic syndrome as an endocrine
disease: is there an effective pharmacotherapeutic strategy
optimally targeting the pathogenesis? Therapeutic
Advances in Cardiovascular Disease 2007;1:7–26.